Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital Post author:Sam Post published:January 31, 2018 Post category:BioPharma The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products. Source: BioSpace You Might Also Like 3 Top Drugmakers Leading Lung Cancer R&D Right Now November 19, 2017 SAGE Therapeutics Announces Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update February 22, 2017 Rumors Surface M&A-Desperate Gilead is Nearing a Deal to Buy Incyte March 12, 2017
SAGE Therapeutics Announces Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update February 22, 2017